Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70–80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food and Dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Vito, Brunetti, Oronzo, Gnoni, Antonio, Licchetta, Antonella, Delcuratolo, Sabina, Memeo, Riccardo, Solimando, Antonio Giovanni, Argentiero, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843273/
https://www.ncbi.nlm.nih.gov/pubmed/31627433
http://dx.doi.org/10.3390/medicina55100698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843273/
https://www.ncbi.nlm.nih.gov/pubmed/31627433
http://dx.doi.org/10.3390/medicina55100698

Ejemplares similares